Cargando…

Ladarixin, an inhibitor of the interleukin‐8 receptors CXCR1 and CXCR2, in new‐onset type 1 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled trial

AIM: To evaluate the ability of ladarixin (LDX, 400 mg twice‐daily for three cycles of 14 days on/14 days off), an inhibitor of the CXCR1/2 chemokine receptors, to maintain C‐peptide production in adult patients with newly diagnosed type 1 diabetes. MATERIALS AND METHODS: A double‐blind, randomized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piemonti, Lorenzo, Keymeulen, Bart, Gillard, Pieter, Linn, Thomas, Bosi, Emanuele, Rose, Ludger, Pozzilli, Paolo, Giorgino, Francesco, Cossu, Efisio, Daffonchio, Luisa, Goisis, Giovanni, Ruffini, Pier Adelchi, Maurizi, Anna Rita, Mantelli, Flavio, Allegretti, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540558/ https://www.ncbi.nlm.nih.gov/pubmed/35589610 http://dx.doi.org/10.1111/dom.14770

Ejemplares similares

Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders
por: Sordi, Valeria, et al.
Publicado: (2023)

CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice
por: Mattos, Matheus Silverio, et al.
Publicado: (2020)

The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
por: Ruffini, Pier Adelchi
Publicado: (2019)

CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
por: Castelli, Vanessa, et al.
Publicado: (2021)

CXCR1/2 pathways in paclitaxel-induced neuropathic pain
por: Laura, Brandolini, et al.
Publicado: (2017)

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment
por: Kemp, Daria Marley, et al.
Publicado: (2017)

Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling
por: Brandolini, Laura, et al.
Publicado: (2015)

The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 (low) Mice
por: Verachi, Paola, et al.
Publicado: (2022)

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
por: Goldstein, Lori J., et al.
Publicado: (2020)

Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
por: Goldstein, Lori J., et al.
Publicado: (2020)

The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)
por: Korbecki, Jan, et al.
Publicado: (2023)

CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
por: Singh, S, et al.
Publicado: (2009)

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017)

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
por: Harms, Mirja, et al.
Publicado: (2023)

Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes
por: Nojima, Hiroyuki, et al.
Publicado: (2016)

CXCR1/CXCR2 Antagonism Is Effective in Pulmonary Defense against Klebsiella pneumoniae Infection
por: Wei, Jing, et al.
Publicado: (2013)

Expression of SDF-1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer
por: JASZCZYNSKA-NOWINKA, KAROLINA, et al.
Publicado: (2014)

The Role of SDF-1/CXCR4/CXCR7 in Neuronal Regeneration after Cerebral Ischemia
por: Cheng, Xi, et al.
Publicado: (2017)

Stromal cell derived factor-1, CXCR4 and CXCR7 gene transcripts in pterygia
por: Bamdad, Shahram, et al.
Publicado: (2016)

Interleukin-8 promotes cell migration via CXCR1 and CXCR2 in liver cancer
por: Bi, Huijuan, et al.
Publicado: (2019)

Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration
por: Chen, Dong, et al.
Publicado: (2015)

Computer‐aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma
por: Yu, Xiao, et al.
Publicado: (2020)

Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges
por: Rajarathnam, Krishna, et al.
Publicado: (2020)

Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2014)

CXCR7 Controls Competition for Recruitment of β-Arrestin 2 in Cells Expressing Both CXCR4 and CXCR7
por: Coggins, Nathaniel L., et al.
Publicado: (2014)

CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members
por: Guo, Kaibo, et al.
Publicado: (2019)

Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis
por: Hernandez, Lorena, et al.
Publicado: (2011)

Correlation of CXCR4/CXCR7 signaling pathway with pre-eclampsia
por: Zheng, Zhi, et al.
Publicado: (2018)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
por: Ngamsri, Kristian-Christos, et al.
Publicado: (2020)

Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial
por: Ferrari, Mauro P., et al.
Publicado: (2013)

CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)

CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection
por: Tavares, Luciana P., et al.
Publicado: (2017)

Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India
por: Mehrotra, Sanjana, et al.
Publicado: (2011)

High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma
por: Wang, Linhui, et al.
Publicado: (2012)

GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells
por: Inaguma, Shingo, et al.
Publicado: (2015)

The Role of SDF-1α-CXCR4/CXCR7 in Migration of Human Periodontal Ligament Stem Cells
por: Xu, Jialei, et al.
Publicado: (2023)

Author Correction: Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration
por: Chen, Dong, et al.
Publicado: (2022)

A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
por: Landoni, Giovanni, et al.
Publicado: (2022)

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
por: Romain, Benoît, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fa8v85jv7c3e2luefceksd45ls